Cargando…
Pharmacogenomic study of heart failure and candesartan response from the CHARM programme
AIMS: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) programme consisted of three parallel, randomized, double‐blind clinical trials comparing candesartan with placebo in patients with heart failure (HF) categorized according to left ventricular ejection...
Autores principales: | Dubé, Marie‐Pierre, Chazara, Olympe, Lemaçon, Audrey, Asselin, Géraldine, Provost, Sylvie, Barhdadi, Amina, Lemieux Perreault, Louis‐Philippe, Mongrain, Ian, Wang, Quanli, Carss, Keren, Paul, Dirk S., Cunningham, Jonathan W., Rouleau, Jean, Solomon, Scott D., McMurray, John J.V., Yusuf, Salim, Granger, Chris B., Haefliger, Carolina, de Denus, Simon, Tardif, Jean‐Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715825/ https://www.ncbi.nlm.nih.gov/pubmed/35736394 http://dx.doi.org/10.1002/ehf2.14026 |
Ejemplares similares
-
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT
por: Dubé, Marie-Pierre, et al.
Publicado: (2021) -
Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure
por: Kassem, Imad, et al.
Publicado: (2020) -
A genetic model of ivabradine recapitulates results from randomized clinical trials
por: Legault, Marc-André, et al.
Publicado: (2020) -
Comparison of genotype clustering tools with rare variants
por: Perreault, Louis-Philippe Lemieux, et al.
Publicado: (2014) -
Construction of a femininity score in the UK Biobank and its association with angina diagnosis prior to myocardial infarction
por: Levinsson, Anna, et al.
Publicado: (2022)